Japanese Scientists Say Use Of Anti-Aging Drug May Begin In 5-10 Years
Muhammad Irfan Published February 18, 2021 | 11:54 AM
Japanese scientists have discovered a mechanism that allows people to get rid of the so-called senescent cells and thus halts the aging process, with the possibility of administering an effective drug that can trigger this mechanism within 5-10 years, professor Makoto Nakanishi of the Institute of Medical Science, the University of Tokyo, told Sputnik
TOKYO (UrduPoint News / Sputnik - 18th February, 2021) Japanese scientists have discovered a mechanism that allows people to get rid of the so-called senescent cells and thus halts the aging process, with the possibility of administering an effective drug that can trigger this mechanism within 5-10 years, professor Makoto Nakanishi of the Institute of Medical Science, the University of Tokyo, told Sputnik.
The age-related weakening of the body's functions is directly related to the fact that human organs accumulate cells triggering systemic inflammatory processes. One of the types of cells that provoke inflammation are the so-called senescent cells. US scientist Leonard Hayflick discovered senescent cells, or the aging process of cells, 60 years ago. He found out that cells can only divide a certain number of times, after which this process stops. Senescent cells lose their ability to divide, accumulate in the body and cause inflammation and aging.
"If you remove these cells, it will be possible to stop the inflammatory processes provoked by them, and, therefore, to achieve a significant improvement in the symptoms of aging. In 2014, we began to study how these cells lose the ability to divide and become senescent cells, and we found a molecular mechanism. We 'aged' a cell. It means that we created a cell with properties common to all aging cells and started to look for something that would kill only these cells." Nakanishi, who heads a collaborative research group, said.
The scientists found out that metabolic enzyme GLS1 is vital for a senescent cell. GLS1 enzyme allows to remove an acidic environment that accumulates in senescent cells and disrupt their main functions.
"Not only senescent cells, but any other cells in which the protein cannot be destroyed and eliminated, become cells that provoke inflammation. Survival of all these cells depends on GLS1, an enzyme that converts glutamine to glutamic acid. Therefore, if we use its inhibitor (inhibitory substance), then we can destroy all cells that provoke inflammation, including senescent cells," the scientist said.
As such an inhibitor, the scientists decided to use a drug that already exists and is undergoing clinical trials as a drug for certain types of cancer, whose cell growth also depends on GLS1.
A team of researchers working with Nakanishi gave the GLS1 inhibitor to aging mice and managed to remove cells responsible for aging-related diseases. Improvements were seen in various organs of the mice.
"Most importantly, this drug already exists and is in the first phase of clinical trials. If it does not cause side effects, then it can probably be used against age-related changes. It is quite possible that its widespread use is actually very close. This is very hopeful. I would like it to be applicable for ordinary elderly people in 5-10 years," Nakanishi said.
Nakanishi believes that if the drug is proven to be safe and effective in removing senescent cells in humans, it will be possible to achieve an increase in life expectancy and a reduction in the gap between overall life expectancy and a healthy state of a person. Now this gap is about 10 years on average.
Recent Stories
Mired in crisis, Boeing reports another loss
Session Awarding Ceremony 2024 held at Cadet College Muzaffarabad
Austrian ski great Hirscher to make comeback under Dutch flag
Pakistan, Japan agrees to convene 'Economic Policy Dialogue'
FM Dar conveys deepest sympathy on torrential rains devastation in UAE
Spain PM Sanchez says weighing resignation after wife's graft probe
Tennis: ATP/WTA Madrid Open results - 1st update
Long-lost Klimt portrait auctioned off for 30 mn euros
Osaka seals first win on clay since 2022 in Madrid
Earthquake jolts Karachi
Sindh minister orders operation after attack on police in Ghotki
TikTok to fight US ban law in courts
More Stories From Health
-
Vaccines save at least 154 million lives in 50 years: WHO
6 hours ago -
UHS to issue MBBS degrees within three months after final result
9 hours ago -
Rawalpindi woman gives birth to six babies
5 days ago -
DC calls for intensive anti-polio drive in ICT
6 days ago -
World Hemophilia Day observed to underscore importance of providing comprehensive care
7 days ago -
Six in a family with heart on the 'right side'
7 days ago
-
Diabetic disease increasing rapidly : Dr. Noor Elahi Memon
7 days ago -
World Hemophilia Day observed
7 days ago -
ATC dismisses bail petition of doctor involved in illegal kidneys transplant
15 days ago -
Dr. Shehzad warns against deviation from WHO guidelines on anti-smoking
15 days ago -
Health activists express concerns over attempts to derail tobacco control
17 days ago -
UHS declares MBBS first prof, MS urology exam results
26 days ago